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Objectives:Our aimwas to evaluate the feasibility and safety of routine transradial approach (TRA) percutaneous
coronary intervention (PCI) for chronic total occlusion (CTO) lesions using the sheathless technique with
standard guiding catheters.
Background: Transradial approach PCIwas applied for CTO lesions. Amajor limitation of TRA CTOPCI is the inabil-
ity to use large guiding catheters because of the relatively small size of the radial artery. Therefore, the sheathless
technique for TRA PCI has been recently developed. However, reports on TRA CTO PCI using the sheathless
technique are still lacking.
Methods: Sixty-eight patients with CTO lesions were enrolled for TRA PCI using the sheathless technique with
standard guiding catheters. The baseline characteristics, coronary angiographic characteristics and major
procedure or access site related complicationswere compared between procedure success and procedure failure
group to determine the predictors of success in sheathless CTO PCI. In-hospital and 30-day clinical outcomes
were also evaluated in this study. Routine assessments of radial artery occlusion via Doppler ultrasound and
pulse oximeter were recorded during one-year clinical follow-up.
Results: The mean duration of CTO by history was 31.8 ± 42.3 months. The 7 Fr standard guiding catheter was
used with the sheathless technique in 91.2%, and bilateral sheathless approach in 42.6% of the study patients.
The procedure-related complications included coronary perforation needing covered stent deployment (2.9%),
cardiac tamponade (2.9%), collateral perforation needing coil deployment (4.4%), and contrast induced nephrop-
athy (2.9%). Only 2 patients (2.9%) experienced forearm ecchymosis at the radial artery access sites. In-hospital
mortality and 30-day all-cause mortality were 2.9%, and 30-day MACEs were 1.5%. The rate of radial artery
occlusion during one-year clinical follow-up was only 3.0%.
Conclusions: It is feasible and safe to routinely use the sheathless technique with standard guiding catheters for
TRA CTO PCI, with a low incidence of procedure-related complications and long-term radial artery occlusion.
©2014 TheAuthors. Published by Elsevier Ireland Ltd. This is an open access article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Chronic total occlusions (CTO) of coronary arteries are widely
encountered in patients undergoing coronary angiography, with an
incidence rate between 18.4% and 52% [1–3]. Despite the advance in
techniques and technology, percutaneous coronary intervention (PCI)
for CTO remains a challenge. Therefore, the attempted rate of CTO PCI
was only 10% to 15% in patients with coronary artery disease, forpartment of Internal Medicine,
Pei Road, Niao Sung District,
886 7 7317123; fax: +886 7
r.
land Ltd. This is an open access articlwhom CTO was the most common reason for coronary artery bypass
surgery [2,3]. Successful CTO PCI seems to be associated with improved
short-term and long-term clinical outcomes and mortality [4,5].
The transfemoral arterial approach (TFA) is the worldwide accepted
method for CTO interventions because the artery can accommodate a
larger guiding catheter, and hence provides better support and a larger
working space. However, the conventional TFA has several clinical and
anatomical limitations including distal abdominal aortic disease, very
tortuous or occluded ilio-femoral arteries, morbid obesity, and long pe-
riod of bed rest required after the procedure. Signiﬁcant hemostatic dif-
ﬁculties can occur with the TFA in obese patients, which may increase
the risk of groin complications, and lead to longer hospitalization.
Transradial approach (TRA) PCI was introduced two decades ago, and
now this technique is being generally applied. The feasibility and safety ofe under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.A 7 Fr Kimny guiding catheter (Boston Scientiﬁc, Grove,MN, USA)was loaded by a 5
Fr 125 cmVTK catheter (VTK, Cook Inc., Bloomington, IN, USA) in order to taper down the
distal tip.
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tion lesions, unprotected left main lesions, carotid artery stenting, and
CTO [6–10]. Recently, the retrograde approach via collaterals was the
most signiﬁcant advance in PCI techniques for CTO, which needs larger
guiding catheters for good backup support and complex devices. Howev-
er, one of the major limitations regarding TRA CTO PCI is the inability of
using larger guiding catheters, due to the relatively smaller size of the
radial arteries compared to that of the femoral arteries. In fact, Saito
et al. [11] determined that the radial artery lumen is smaller than the 7
Fr introducer sheath in almost one-third of the men and two-thirds of
the women in Japan.
The 7Fr standard guiding catheters had the same diameter of the
outer lumen compared with a 5Fr artery sheath which was far smaller
than the usual radial artery size. Using the sheathless technique could
facilitate any 7Fr standard guiding catheter to be available in transradial
CTO intervention.Mamas and colleagues [12] reported a pilot study of a
6.5 Fr sheathless guiding catheter system that may resolve the limita-
tion of size in TRA PCI, but cannot change guiding catheters accommo-
dated with each patient when performing CTO PCI. Although the
sheathless guiding catheter technique has recently been applied to
complex PCI, such as bifurcation lesions and rotational atherectomy
[13–15]. Studies to investigate the feasibility and safety of CTO PCI
using the sheathless technique are still lacking.
The aim of the present pilot studywas to evaluate the safety and fea-
sibility of the sheathless technique using standard guiding catheters for
TRA CTOPCI in routine practice, the predictors of success sheathless CTO
PCI and the in-hospital and 30-day clinical outcomes.
2. Materials and methods
2.1. Patient population
Between January 2010 and June 2012, 72 patients who received TRA
CTO PCI using the sheathless techniquewith standard guiding catheters
were recruited. Exclusion criteria included: (1) a history of acute or re-
cent ischemic or hemorrhagic stroke (b2 months), (2) an episode of
acute or recentmyocardial infarction (MI), (3) major surgery or trauma
within the preceding 2 months and (4) end-stage renal disease (ESRD).
Four patients with recent MI undergoing staged revascularization for
CTO lesions were excluded. Finally, 68 patients were enrolled into this
study for evaluation. All patients gave their written informed consent
prior to participation in the study, and the study protocol was approved
by our hospital's Internal Research Board Committee.
2.2. Operator selection
The CTO intervention procedures were limited to one experienced
operator (C.J.W.) in our institution. The experienced operator met the
criteria of “CTO operators” who had speciﬁc proctored experience of
more than 100 CTOs [16].
2.3. Deﬁnitions
CTO lesion was deﬁned according to the thrombolysis in myocardial
infarction grade (TIMI) of 0 for more than 3 months, and with the pres-
ence of typical angina or reversible myocardial ischemia in a thallium
stress study. The duration of occlusionwas estimated by the history of an-
gina, history of MI in the same territory, or previous coronary angiogra-
phy. The deﬁnition of procedure success was that successful guidewire
and balloon were crossed with or without ﬁnal stenting, with a residual
diameter stenosis of b30%, and the presence of a ﬁnal TIMI 3 ﬂow.
Major adverse cardiac events (MACEs) included cardiovascular death, re-
current MI, or urgent revascularization during the same hospitalization.
Contrast induced nephropathy (CIN) was deﬁned as an increase of at
least 0.5mg/dL or at least 25% of baseline serum creatinine concentration
after exposure to contrast media within 48 to 72 h. Acute stentthrombosis was deﬁned as an episode occurring within 24 h, and sub-
acute stent thrombosis within 30 days after the index procedure.2.4. Procedure and protocol
2.4.1. Radial arterial puncture and sheathless technique steps
Both radial arteries were evaluated by either Allen's test or portable
Doppler ultrasoundbefore the PCI procedures. A 5 Fr or 6 Fr convention-
al arterial sheath was inserted via the usual radial artery access site,
deﬁned as a puncture site about 3–5 cm above the styloid process. To
prevent vasospasm and thromboembolic events, a cocktail solution
consisting of 200 μg nitroglycerin and 60 I.U. per kilogram heparin
was administered via the artery sheath. Before performing CTO PCI, a
standard guiding catheter was used for diagnostic coronary angiogra-
phy. A 0.035″ 260 cm J-tipped Teﬂon wire was inserted and reached
the proximal ascending aorta, and then the 5 Fr artery sheath was ex-
changed to a 7r Fr standard guiding catheter which was loaded by a 5
Fr 125 cm VTK catheter (VTK, Cook Inc., Bloomington, IN, USA) in
order to taper down the distal tip (Fig. 1), with the sheathless technique
following From et al.'s report [17]. After the procedures, the standard
guiding catheter was removed along with the J-tip Teﬂon wire, and
the access site was compressed by a TR band (Terumo, Tokyo, Japan).2.5. Selection of standard guiding catheters
At ﬁrst, a 5 Fr Ikari IL 3.5 guiding catheter (Terumo, Tokyo, Japan), or
a 6 Fr KimnyMini-radial guiding catheter (Boston Scientiﬁc, Grove, MN,
USA) was used for diagnostic coronary angiography. Standard
nonhydrophilic guiding catheters consisting of a 7 Fr Kimny Mini-
radial guiding catheter (Boston), a 7 Fr 100 cm long BL (backup left)
3.5–4 guiding catheter (Terumo), or a 7 Fr 100 cm short AL (Amplatz
left) 1 guiding catheter (Terumo) was selected for the antegrade or ret-
rograde approach according to each individual patient. Before PCI for
CTO lesions, a second intracoronary bolus of 5000 I.U. heparin was
administered via the guiding catheters to keep activated clotting time
250 to 300 s.
Table 1
Baseline demographic characteristics of study patients.
All
(n = 68)
Success
(n = 58)
Failure
(n = 10)
P value
Demographics
Age (years) 62.8 ± 11.4 62.3 ± 10.8 65.5 ± 14.8 0.298⁎
Male 57 (83.8) 51 (87.9) 6 (60.0) 0.049
Body mass index (kg/m2) 25.7 ± 3.8 25.8 ± 3.8 25.2 ± 4.0 0.641
Creatinine (mg/dL)§ 1.1 ± 0.4 1.0 ± 0.3 1.6 ± 0.9 0.066§
Cholesterol (mg/dL) 150.9 ±
35.5
148.2 ±
30.3
167.5 ±
58.6
0.323
LDL (mg/dL) 114.7 ±
36.1
111.5 ±
32.8
117.1 ±
47.3
0.508
HbA1C 7.7 ± 1.8 7.5 ± 1.6 8.1 ± 2.4 0.781
Risk factors
Hypertension 55 (80.9) 46 (79.3) 9 (90.0) 0.673
Diabetes mellitus 27 (39.7) 23 (39.7) 4 (40.0) 1.000
Dyslipidemia 28 (41.2) 22 (37.9) 6 (60.0) 0.297
Smoking habit 15 (22.1) 15 (25.9) 0 (0) 0.102
Comorbidity
Previous MI 19 (27.9) 18 (31.0) 1 (10.0) 0.262
Previous CABG 4 (5.9) 3 (5.2) 1 (10.0) 0.479
Previous stroke 9 (13.2) 9 (15.5) 0 (0) 0.336
Peripheral vascular
disease
4 (5.9) 4 (6.9) 0 (0) 1.000
ESRD 5 (7.4) 3 (5.2) 2 (20.0) 0.153
Duration of CTO (months) 31.8 ± 42.3 32.7 ± 43.0 26.4 ± 39.7 0.547
LVEF (%) 57.7 ± 15.5 58.2 ± 15.8 54.3 ± 13.5 0.393
LDL indicates low-density lipoprotein; HbA1C, hemoglobin A1C; MI, myocardial
infarction; CABG, coronary artery bypass graft; ESRD, end-stage renal disease; CTO,
chronic total occlusion; and LVEF, left ventricle ejection fraction.
⁎ Data are presented as mean ± SD or number (%) of patients.
§ Creatinine level was calculated after excluding patients with end-stage renal disease.
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Guidewire selection for the antegrade approachwas decided by oper-
ator after diagnostic coronary angiography. The guidewires ranged from
those with usual stiffness as Runthrough Floppy (Terumo, Japan) or
Rinato wires (Asahi, Tokyo, Japan), hydrophilic wires such as Pilot (Ab-
bott, Abbott Park, IL, USA) or Fielder wires (FC or XT; Asahi) or SION
(Asahi), and stepwise harder-tip wires such as Miracle (3, 4.5, 6, 12 g;
Asahi) or Conquestwires (9, 12, or 20/8 g; Asahi). The selected guidewire
for the antegrade approachwas placed at the proximal cap of the CTO site
with a 1.8 Fr microcatheter (Finecross; Terumo). For the retrograde ap-
proach, we super-selected a suitable collateral vessel with a
microcatheter, and then selected guidewires including either Fielder-FC
(Asahi), Fielder-XT (Asahi), or SION (Asahi) wires under a microcatheter
support to advance into the distal part of the CTO lesion. Externalization
was completed with a 0.010″ long RG-3 300 cm guidewire (Asahi).
2.7. Bilateral transradial approach for simultaneous coronary injections
If antegrade approach failed or was infeasible due to unfavorable
anatomy, the retrograde approach using bilateral simultaneous coro-
nary injections was tried through suitable retrograde collaterals
consisting of septal collaterals, epicardial collaterals, saphenous vein
grafts, or the left internal mammary artery. Recanalization by retro-
grade approach required one or more complex techniques, such as
kissing wire technique, controlled antegrade and retrograde subintimal
tracking (CART) technique, reverse CART technique, knuckle wire tech-
nique, or parallel-wire technique. After the retrograde guidewire had
passed the occluded segment, the retrograde guidewirewasmanipulat-
ed into the antegrade guiding catheter. Then, the original 190 cm
guidewire was exchanged for a long RG-3 300 cm guidewire through
a microcatheter. Stepwise balloon angioplasty was done and was
followed by the evaluation of intravascular ultrasound study (IVUS)
for the preparation of subsequent stenting to target CTO lesions. After
successful balloon dilatation, either bare-metal stents (BMS), or drug-
eluting stents (DES), were deployed, based on the patient's preference.
(Since general health insurance guidelines in Taiwan only reimburse for
BMS, the additional cost of DES needs to be paid by the patient.)
2.8. Medications
Patients received medical treatments including oral aspirin
(100 mg/day) and anti-ischemic agents. The pre-medication with a
loading dose of clopidogrel (300 or 600 mg) was given 4 to 12 h before
the index procedure. A post-procedure dose of clopidogrel (300 mg)
was also administered following the maintenance dose of clopidogrel
(75 mg per day) for at least 9 months after the implantation of DES, or
at least 3 months after BMS deployment or balloon angioplasty.
2.9. Assessment of the predictors of success in sheathless CTO PCI
To determine the predictors of success in sheathless CTO PCI, the
enrolled patientswere divided into procedure success and procedure fail-
ure groups. Baseline characteristics, coronary angiographic characteristics
andmajor procedural or access site related complicationswere compared
between procedure success and procedure failure group.
2.10. Assessment of in-hospital outcomes and 30-day clinical outcomes
In-hospital outcomeswere classiﬁed as in-hospitalmortality, cardiac
death, recurrent myocardial infarction (MI), stent thrombosis, arrhyth-
mia or stroke, in-hospital MI was deﬁned by elevation of cardiac tropo-
nin values N5 times upper reference limit in patients with normal
baseline values or a rise of cardiac troponin values N20% if the baseline
values are elevated as 3rd universal deﬁnition with type 4b PCI relatedMI. Death from uncertain causes was also classiﬁed as cardiac death.
30-day MACEs were deﬁned as above.
2.11. Assessment of radial artery occlusion
All patientswere followed up to evaluate radial artery occlusion at the
access sites, physical examination for radial pulsation, Doppler ultrasound
for blood ﬂow of the radial arteries at access sites, and pulse oximeter
were performed during one-year clinical follow-up. Radial artery occlu-
sion was deﬁned as the absence of a radial pulsation with the absence
of bloodﬂowdetected byDoppler ultrasound probe. In order to eliminate
the blood supply from collaterals, the ipsilateral ulnar artery was com-
pressed for 30 s before and during radial artery assessment.
2.12. Statistical analysis
Data were presented as means ± SD. Categorical variables between
the successful procedure group and the failed procedure group were
compared using chi-square test or Fisher exact test as appropriate.
Moreover, continuous variables between the two groups of study pa-
tients were compared byMann–Whitney U test. Finally, statistical anal-
yses were performed using a statistical software program (SPSS version
19.0; SPSS Inc.; Chicago, Illinois, U.S.A.). All P valueswere two-sided, and
the level of statistical signiﬁcance was set at 0.05.
3. Results
3.1. Baseline demographic characteristics of study patients
A total of 68 patients were enrolled in this study, with the procedure
success rate of up to 85.3% (58 successful cases, and 10 failed cases sep-
arately). Table 1 reveals the baseline demographic characteristics of the
study patients. The mean age of all patients was 62.8 ± 11.4 years, and
the prevalence of male patients was 83.8%. There were no signiﬁcant
differences in age, body mass index, cholesterol level, low-density
lipoprotein (LDL) level and hemoglobin A1C (HbA1C) between the
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paring with the procedural success group, the procedure failed group
had fewer males (60.0% vs. 87.9%, P = 0.049). After excluding patients
with end-stage renal disease, the creatinine level in the procedure suc-
cessful groupwas lower than that in the procedure failed groupwithout
a signiﬁcant difference (1.0±0.3mg/dL vs. 1.6±0.9mg/dL, P=0.066).
The prevalence of risk factors for coronary artery disease, including hy-
pertension, diabetes mellitus, dyslipidemia, and smoking habit did not
differ between the two groups. Moreover, the incidence of comorbidi-
ties including previous myocardial infarction (MI), previous coronary
artery bypass graft history, previous stroke, peripheral vascular disease,
and end-stage renal disease was similar between the two groups. The
durationof CTO and the left ventricular ejection fractionwas also similar
between the procedure successful group and the procedure failed group
(32.7 ± 43.0 months vs. 26.4 ± 39.7 months, P = 0.547; 58.2 ± 15.8%
vs. 54.3 ± 13.5%, P = 0.393, respectively).
3.2. Coronary angiographic characteristics of CTO lesions
Table 2 shows the coronary angiographic characteristics of study pa-
tients. Ad hoc PCIwas performed in 27 patients (39.7%), but no signiﬁcant
difference was found between the procedure successful group and the
procedure failed group. The total procedural time, ﬂuoroscopy time, and
contrast volumewere similar between the two groups. The average num-
ber of access time of the radial arteries was 1.8 ± 1.0, and in the proce-
dure failed group radial arteries were frequently punctured when
compared with the procedure successful group, although the difference
did not reach a level of signiﬁcance (2.3 ± 1.6 vs. 1.7 ± 0.9, P = 0.375).
A 7 Fr standard guiding catheter for sheathless technique was used inTable 2
Coronary angiographic characteristics of study patients.
All
(n = 68)
Success
(n = 58)
Failure
(n = 10)
P value
Ad hoc PCI 27 (39.7) 22 (37.9) 5 (50.0) 0.502⁎
Total procedure time
(minutes)
156.7 ±
65.4
153.6 ±
69.3
173.8 ±
34.9
0.252
Fluoroscopy time (minutes) 77.4 ± 41.2 76.0 ± 43.7 84.7 ± 25.8 0.395
Contrast volume (mL) 440.9 ±
173.0
437.1 ±
170.9
461.4 ±
197.1
0.695
Access time of radial
arteries
1.8 ± 1.0 1.7 ± 0.9 2.3 ± 1.6 0.375
Assess time ≧2 34 (50.0) 29 (50.0) 5 (50.0) 1.000
7 Fr sheathless guiding
catheter
62 (91.2) 52 (89.7) 10 (100.0) 0.581
Contralateral injection 49 (72.1) 41 (70.7) 8 (80.0) 0.714
Bilateral sheathless
approach
29 (42.6) 25 (43.1) 4 (40.0) 1.000
Multiple-vessel disease 61 (89.7) 52 (89.7) 9 (90.0) 1.000
Target CTO lesion
LAD 27 (39.7) 22 (37.9) 5 (50.0) 0.502
LCX 4 (5.9) 4 (6.9) 0 (0) 1.000
RCA 37 (54.4) 32 (55.2) 5 (50.0) 1.000
Collaterals use 52 (76.5) 45 (77.6) 7 (70.0) 0.689
Septal 33 (48.5) 28 (48.3) 5 (50.0) 1.000
Epicardial 16 (23.5) 14 (24.1) 2 (20.0) 1.000
Graft 3 (4.4) 3 (5.2) 0 (0) 1.000
Retrograde success 31 (45.6) 28 (48.3) 3 (30.0) 0.326
Occlusion lesion
length (mm)
74.7 ± 26.8 74.1 ± 26.1 77.5 ± 31.5 0.733
Syntax score 19.5 ± 10.3 18.5 ± 9.9 25.1 ± 11.0 0.091
Stent use
Drug-eluting stent 42 (61.8) 41 (70.7) 1 (10.0) b0.001
Bare metal stent 18 (26.5) 17 (29.3) 1 (10.0) 0.270
Balloon angioplasty 5 (7.4) 0 (0) 5 (50.0) b0.001
IVUS-guided PCI 46 (67.6) 43 (74.1) 3 (30.0) 0.010
Rotational atherectomy 4 (5.9) 3 (5.2) 1 (10.0) 0.479
PCI indicates percutaneous coronary intervention; CTO, chronic total occlusion; LAD, left
anterior descending artery; LCX, left circumﬂex artery; RCA, right coronary artery; IVUS,
intra-vascular ultrasound.
⁎ Data are presented as mean ± SD or number (%) of patients.62 patients (91.2%) during TRA CTO PCI. Contralateral injection for
antegrade/retrograde approaches and simultaneous injection for CTO le-
sions were applied in 72.1% of the study patients, and the bilateral
sheathless approachwas used in 42.6%. Themost common target CTO le-
sion was the right coronary artery (54.4%), followed by the left anterior
descending artery (39.7%), and left circumﬂex artery (5.9%),without rela-
tionship to procedure success. Collaterals were used in 52 patients
(76.5%). The most frequently used collaterals were septal collaterals
(48.5%), followed by epicardial collaterals (23.5%), and bypass grafts
(4.4%). The occlusion lesion length of CTO was about 74.7 ± 26.8 mm,
and there was no difference between the two groups. When comparing
with the procedural successful group, Syntax score in the procedure failed
group was higher than that in the procedure successful group, although
the difference did not reach a level of signiﬁcance (25.1 ± 11.0 vs.
18.5 ± 9.9, P = 0.091). The procedure successful group received more
DES implantation for CTO lesions than those of the procedure failed
group (70.7% vs. 10.0%, P b 0.001). Furthermore, IVUS-guided PCI was
also more frequently used in the procedure successful group than in the
procedure failed group (74.1% vs. 30.0%, P=0.010). In addition, rotation-
al atherectomy was performed on 5.9% of the study patients.
3.3. Procedure-related complications of sheathless TRA CTO PCI
Table 3 summarizes data for the major procedural and access site
complications during sheathless TRA CTO PCI. In the procedure success-
ful group, 2 patients (2.9%) suffered from cardiac tamponade, and need-
ed emergent pericardiocentesis followed by pig-tail drainage. One
patient (1.5%) in the procedure successful group had aortic dissection
from the right coronary artery, and donor vessel dissection occurred in
another 2 patients (2.9%), who were treated with stent deployment
under IVUS guidance. Moreover, 2 patients (2.9%) suffered from type
III coronary perforation (the Ellis Classiﬁcation Scheme) in the proce-
dural successful group. Both of these 2 patients needed the deployment
of Cover stent (Boston) and one of them even needed emergent surgery
to repair coronary perforation. The perforation of collaterals requiring
coil deployment occurred in 3 patients (4.4%). However, there were
no differences between the procedure successful group and the proce-
dure failed group with respect to procedure-related complications.
Two patients (2.9%) experienced contrast induced nephropathy (CIN),
and completely recovered with conservative treatments. Only 2 pa-
tients (2.9%) experienced forearm ecchymoses after the procedure
without clinical signs of compartment syndrome or need of blood trans-
fusion or surgical intervention.
3.4. Clinical outcomes and rate of radial artery occlusion
Table 4 presents data for in-hospital adverse events and 30-day clin-
ical outcomes of the study patients. In-hospital mortality happened in 2
patients (2.9%), one of whom had cardiogenic shock and the other hadTable 3
Major procedural and access site complications of study patients.
All
(n = 68)
Success
(n = 58)
Failure
(n = 10)
P value
Major procedural complications
Cardiac tamponade 2 (2.9) 2 (3.4) 0 (0) 1.000⁎
Aortic dissection 1 (1.5) 1 (1.7) 0 (0) 1.000
Donor vessel dissection 2 (2.9) 2 (3.4) 0 (0) 1.000
Coronary perforation needing
Cover stent deployment
2 (2.9) 2 (3.4) 0 (0) 1.000
Collaterals perforation needing
coil deployment
3 (4.4) 2 (3.4) 1 (10.0) 0.384
Contrast-induced nephropathy 2 (2.9) 1 (1.7) 1 (10.0) 0.274
Access site complications
Forearm ecchymosis 2 (2.9) 2 (3.4) 0 (0) 1.000
⁎ Data are presented as number (%) of patients.
Table 4
In-hospital outcomes and 30-day clinical outcomes of study patients.
All
(n = 68)
In-hospital outcomes
In-hospital mortality 2 (2.9)⁎
Cardiac death 1 (1.5)
Recurrent myocardial infarction 1 (1.5)
Stent thrombosis 1 (1.5)
Arrhythmia 2 (2.9)
Stroke 1 (1.5)
30-day clinical outcomes
30-day all-cause mortality 2 (2.9)
30-day MACEs 1 (1.5)
MACEs indicate major adverse cardiac events.
⁎ Data are presented as number (%) of patients.
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enced coronary perforation rescued by emergent intra-aortic balloon
pump (IABP), extra-corporeal membrane oxygenation (ECMO) and
emergent surgery. One patient (1.5%) experienced recurrent MI 3 days
later after the index procedure caused by an episode of subacute instent
thrombosis, and received urgent revascularization. Two patients (2.9%)
had arrhythmia during procedure, consisting of one episode of atrial ﬁ-
brillation in the procedure successful group, and one episode of ventric-
ular tachycardia in the procedure failed group, which were both
successfully converted by cardioversion. Complication from embolic
stroke occurred in 1 patient (1.5%). Thirty-day clinical outcomes, similar
to in-hospital outcomes, revealed a low incidence of 30-day all-cause
mortality (2.9%) and 30-day MACEs (1.5%). Finally, the rate of radial
artery occlusion was evaluated in a total of 66 patients (Table 5). Radial
artery occlusion during one-year clinical follow-up was found only in 2
patients (3.0%), one of whom was in the procedure successful group
and the other one in the procedure failed group. Only 1 patient (1.5%)
had poor circulation of the ﬁngers (pulse oximeter b96%) during
compressing ipsilateral ulnar artery.
4. Discussion
To the best of our knowledge, this is the ﬁrst study to investigate the
procedural and clinical outcomes of TRA CTO PCI using the sheathless
technique with standard guiding catheters. A high procedural success
rate was achieved up to 85.3% with minimal procedural complications
(10/68, 14.7%), low access site complication rate (2/68, 2.9%), and low
in-hospital adverse events (4/68, 5.9%). Moreover, low incidence of
radial artery obstruction at access sites during one-year clinical
follow-up was only 3.0%. Accordingly, we concluded that TRA CTO PCI
using the sheathless technique with standard guiding catheters was
applicable and safe.
4.1. Applications and limitations of the TRA CTO PCI
With respect to CTO lesions, our group previously reported the fea-
sibility and safety of bilateral forearm PCI for CTO lesions, in which
95.3% of the patients undergoing TRA had a high procedure successTable 5
Clinical evaluation and rates of radial artery occlusion of study patients.
All
(n = 66)
Radial artery occlusion during one-year follow-up 2 (3.0)⁎
Absence of radial pulsation (%) 3 (4.5)
Absence of blood ﬂow (%) 2 (3.0)
Pulse oximeter b96% (%) 1 (1.5)
⁎ Data are presented as number (%) of patients.rate (87.1%) and a low access site complication rate (3.5%) [10,28,29].
As with previous reports, high successful recanalization rate in our
previous study for TRA CTO PCI was dependent on complex devices
and new techniques, such as the CART technique [18–20]. Indeed, the
fundamental key point of the CTO PCI procedure is a good backup sup-
port from larger guiding catheters. Conventional 6 Fr guide catheter sys-
tems may offer enough working space for complex devices or PCI
techniques, but is not excellent for backup support for CTO PCI. There-
fore, 7 Fr guiding catheters were exchanged commonly during TRA
CTOPCI. However, themost critical limitation of TRAPCI is the relatively
small size of the radial artery in comparison to the femoral artery. Saito
et al. [11] reported that, in a Japanese population, a 7 Fr conventional
artery sheaths could not be physically inserted via the radial artery in
28.5% of themale patients and 59.7% of the female patients. During clin-
ical follow-up, 6–11% of the occlusion rate was reported with a 6 Fr ar-
tery sheath system, and 1–7% evenwith a 5 Fr system [21–23]. Our prior
research found that although a conventional 7 Fr artery sheath could be
inserted via high radial artery sites with only 3.5% forearm ecchymoses
of access sites, puncture via high radial artery site was more difﬁcult
than via the usual radial artery site, and required a learning curve [10].
4.2. Routine utilization of sheathless technique for TRA CTO PCI
The recent sheathless guiding catheter technique may resolve the
crucial limitation of the radial artery during TRA PCI [13–15]. In this
study, a 7 Fr guiding catheter for sufﬁcient backup support was utilized
in 91.2% of study patients. Mamas et al. [12] reported the feasibility and
safety of using the 6.5 Fr sheathless guiding catheter system during TRA
PCI, in which two thirds of their patients presentedwith acute coronary
syndrome but none had CTO lesions. Moreover, the sheathless guide
catheter system is specially designed with a hydrophilic coated device
(Sheathless Eaucath, Asahi Intecc, Japan), and has the beneﬁts of a low
incidence of radial spasm (5.0%) and radial occlusion at 2 months
(2.0%) [12]. In our study, we only enrolled patients with CTO lesions,
and tested the sheathless standard guiding catheter to create a larger
working space and better backup support. During TRA CTO PCI using
the sheathless technique with standard guiding catheters, multiple
complex procedures were successfully performed, such as CART or
reverse CART technique, externalization, thrombectomy with a distal
protection device, IVUS-guided PCI, kissing or anchoring balloon tech-
niques, rotational atherectomy, and even deployment of Cover stent
(Boston). Moreover, given the reason of unavailability of the 6.5 Fr
sheathless guiding catheter system (Sheathless Eaucath, Asahi Intecc,
Japan) in Taiwan, standard guiding catheters were applied for the
sheathless technique, which provides the additional beneﬁts of being
easily available and manipulated for experienced cardiologic interven-
tionists. In the ﬁeld of TRA CTO interventions, we successfully down-
sized the conventional arterial sheath from 7–8 Fr (transfemoral PCI),
6 Fr (TRA PCI) to 5 Fr (sheathless guiding catheter system) to prevent
complications of radial artery access sites. Only 2 patients (2.9%) in
this study had forearm ecchymosis. Furthermore, the total procedure
time was longer reaching up to 156.7 ± 65.4 min because of CTO inter-
ventions. However, no patient suffered from severe radial artery spasm
that would have aborted the procedure, and the rate of radial artery
occlusion rate in our study was only 3.0%, which is consistent with
another published report (2.0%) [12].
4.3. Procedure-related complications of the sheathless guiding catheters
In our study, collateral branches were used in 76.5% of patients for
retrograde CTO interventions. Three patients (4.4%) in our study had
epicardial collateral perforation needing coil deployment, which was
slightly higher than the previously reported data of a 3.8% septal collat-
eral perforation rate [24]. In our study, epicardial collaterals (23.5%)
were more frequently selected for retrograde approach, thus resulting
inmore complications than septal collaterals. Despite the use of a larger
40 H.-C. Chen et al. / IJC Heart & Vasculature 6 (2015) 35–41amount of contrast media (440.9 ± 173.0 mL), the incidence of CIN in
our study patients was only 2.9%, which is similar to our previous report
(5.4%) and the report in a multicenter CTO registry of Japan (1.2%)
[24,25]. About one third of the patients in this study received Ad hoc
PCI for CTO lesions [29], which indicates that the sheathless technique
for TRA CTO PCI may become a “routine” procedure at our center. How-
ever, we must point out the importance of planning and having a clear
roadmap for coronary angiography in light of the higher ratio of Ad
hoc PCI in the procedure failed group (50.0%). When compared with
our previous study [10], therewere no signiﬁcant differences in the pro-
cedure time (157min vs. 162min) and theﬂuoroscopy time (77min vs.
70 min) between sheathless TRA CTO PCI and conventional TRA CTO
PCI, which demonstrated that the set-up and manipulation of the
sheathless system with standard guiding catheters were not time-
consuming. The procedure-related complications such as cardiac
tamponade were also similar between the sheathless TRA CTO PCI in
this study and the conventional TRA CTO PCI [10]. Although the
sheathless guiding catheters appear to provide better backup support,
we should keep in mind again that the larger size of a guiding catheter
might be more common with aortic dissection or donor vessel dissec-
tion. Major in-hospital events, including emergent bypass surgery or
PCI, recurrent MI, stroke, cardiac tamponade and cardiac death, were
similar to previous reports in CTO studies [18–20,26,27].4.4. Access-site vascular complications after transradial PCI
In our study, only 2 access-site vascular complications (ASVC) were
recorded during the sheathless TRA CTO PCI. The two cases were catego-
rized as “very early” and “early” diagnoses of ASVC. No need for surgery in
our study. Burzotta et al. [30] had concluded that prompt recognition is
pivotal as “late” diagnosis which is associated to the need for surgery.
Compared with standard arterial sheath technique, the sheathless tech-
nique was not associated with higher ASVC in our study. We concluded
again that TRA CTO PCI using the sheathless technique with standard
guiding catheterswas safewithout ASVC if prompt recognitionwasmade.4.5. Limitation
There are some limitations in our study. Firstly, the tip of the standard
guiding catheter was tapered down by the VTK catheter, which was not
completely ﬁt in the inner diameter of the standard guiding catheters. Al-
though only 2 patients had forearm ecchymoses and another 2 patients
had radial artery occlusion, this sheathless technique may increase the
potential intimal injury of radial artery. Secondly, following the ﬁrst lim-
itation, the potential intimal injury or occlusion of the radial artery may
be underestimated, because the actual diameter of the radial artery at ac-
cess siteswas notmeasured. Finally,we did not randomize the patients to
compare the sheathless with the conventional guiding catheters, and the
number of patient population in this study is relatively small.5. Conclusions
It is feasible and safe to routinely use the sheathless technique
with the standard guiding catheters for TRA CTO PCI with a low inci-
dence of procedure-related complications. The incidence of radial
access site complication and the rate of radial artery occlusion were
also low.Conﬂict of interest
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